Quest Diagnostics Inc (DGX) fundamentals from SEC filings — revenue $11.0B, net margin 9.0%, diluted EPS $8.75 in FY2025. Revenue, margins, EPS and free cash flow, year by year.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $10.8B | $9.9B | $9.3B | $9.9B | $11.0B |
| Net income | $2.0B | $946.0M | $854.0M | $871.0M | $992.0M |
| Net margin | 18.5% | 9.6% | 9.2% | 8.8% | 9.0% |
| Diluted EPS | $15.55 | $7.97 | $7.49 | $7.69 | $8.75 |
| Free cash flow | $1.8B | $1.3B | $864.0M | $909.0M | $1.4B |
Figures are as reported to the SEC (EDGAR companyfacts), in the filer's own fiscal years.
Sign in to PortfolioX for the full analysis — ten years of history, segment and geographic breakdowns, valuation multiples, analyst estimates and filings. · PortfolioX home